Successful treatment with caspofungin of hepatosplenic candidiasis resistant to liposomal amphotericin B

被引：23
|
作者：
Sorà, F [1 ]
Chiusolo, P [1 ]
Piccirillo, N [1 ]
Pagano, L [1 ]
Laurenti, L [1 ]
Farina, G [1 ]
Sica, S [1 ]
Leone, G [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Ist Ematol, Rome, Italy
来源：
CLINICAL INFECTIOUS DISEASES | 2002年 / 35卷 / 09期
关键词：
D O I：
10.1086/343748
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1135 / 1136
页数：2
相关论文
共 50 条
  • [31] Caspofungin versus liposomal amphotericin B for empirical therapy - Reply
    Walsh, TJ
    Donowitz, GR
    dePauw, BE
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (04): : 413 - 414
  • [32] Caspofungin and liposomal amphotericin B used singly and in combination for the treatment of experimental cerebral aspergillosis
    Ullmann, I.
    Strahm, R.
    Leib, S. L.
    Zimmerli, S.
    MYCOSES, 2009, 52 : 122 - 123
  • [33] Amphotericin B liposomal/caspofungin/micafunginLack of efficacy: case report
    Reactions Weekly, 2021, 1871 (1) : 34 - 34
  • [34] Caspofungin and liposomal amphotericin B therapy of experimental murine scedosporiosis
    Bocanegra, R
    Najvar, LK
    Hernandez, S
    McCarthy, DI
    Graybill, JR
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (12) : 5139 - 5141
  • [35] Combination therapy with caspofungin and liposomal amphotericin B for invasive aspergillosis
    Elanjikal, Z
    Sörensen, J
    Schmidt, H
    Dupuis, W
    Tintelnot, K
    Jautzke, G
    Klingebiel, T
    Lehrnbecher, T
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (07) : 653 - 656
  • [36] Caspofungin Versus Liposomal Amphotericin B Are They Really Comparable? Reply
    Walsh, Thomas J.
    Maertens, Johan A.
    Madero, Luis
    Reilly, Anne F.
    Lehrnbecher, Thomas
    Groll, Andreas H.
    Jafri, Hasan S.
    Green, Michael
    Nania, Joseph J.
    Bourque, Michael R.
    Wise, Beth Ann
    Strohmaier, Kim M.
    Taylor, Arlene F.
    Kartsonis, Nicholas A.
    Chow, Joseph W.
    Arndt, Carola A. S.
    dePauw, Ben E.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (10) : 986 - 987
  • [37] HEPATOSPLENIC FUNGAL INFECTION - CT AND PATHOLOGICAL EVALUATION AFTER TREATMENT WITH LIPOSOMAL AMPHOTERICIN-B
    SHIRKHODA, A
    LOPEZBERESTEIN, G
    HOLBERT, JM
    LUNA, MA
    RADIOLOGY, 1986, 159 (02) : 349 - 353
  • [38] Safe and successful endoarterial infusion of liposomal amphotericin B in treatment of mucormycosis
    Mansueto, P
    Rizzo, M
    Affronti, M
    Malta, R
    Carmina, E
    Mansueto, S
    Masellis, M
    Rini, GB
    MICROBIOLOGICA, 2003, 26 (04): : 395 - 398
  • [39] Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis
    Brown, M
    Noursadeghi, M
    Boyle, J
    Davidson, RN
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (01) : 203 - 205
  • [40] ANIDULAFUNGIN IN COMPARISON TO FLUCONAZOLE, AMPHOTERICIN B DEOXYCHOLATE, AMPHOTERICIN B LIPOSOMAL, CASPOFUNGIN AND MICAFUNGIN FOR THE TREATMENT OF INVASIVE CANDIDIASIS AMONG NON-NEUTROPENICPATIENTS ABOVE 16 YEARS: BAYESIAN MIXED TREATMENT COMPARISON (MTC)
    Diaz, J. A.
    Huerfano, C.
    Nino, C. P.
    Alzate, J. P.
    Urrego-Novoa, J. R.
    Moreno, J. A.
    Prieto, V. A.
    VALUE IN HEALTH, 2015, 18 (03) : A228 - A228
12345